17Aug
UK Life Sciences and Healthcare Newsletter - August 2020: COVID-19 – How Have Listed Companies Fared?
COVID-19 has had a significant financial impact on many listed companies and, in recent months, there has been a marked increase in equity capital raises by listed companies. As at 22 July 2020, there have been over 100 secondary equity fundraisings in excess of £10 million on the Main Market and AIM since the COVID lockdown period began. Some have had to raise emergency capital, on short notice and often at significant discounts, whereas others have sought to shore up their balance sheets as...
By:
Dechert LLP
Source Url: https://www.jdsupra.com/legalnews/uk-life-sciences-and-healthcare-82301/
Related
Years ago, as a naïve associate at a semi-prestigious law firm (sorry Lois), I got the short end of ...
Read More >
The U.S. Court of Appeals for the First Circuit has held in Sun Capital Partners III, LP v. New Engl...
Read More >
Have you ever had any foreign nationals “visit” your company from one of your entities outside the...
Read More >
The coronavirus outbreak has hindered many operations of the federal government, including the US re...
Read More >
Romanian government details UK citizens’ residence, employment and travel rights in case of a no-de...
Read More >
Since January 1, 2019, Portland has imposed a 1% gross receipts surcharge tax on “large retailers.”...
Read More >